Full Committee

Tackling the Opioid Crisis: A Whole-of-Government Approach

Type: Full Committee Hearing

Date: Tuesday, December 17th, 2019

Time: 10:00am

Location: Dirksen Senate Office Building 226

Presiding: Senator Ernst

Panel I

Mr. Kemp Chester

Mr. Kemp Chester
Assistant Director of the National Opioids and Synthetics Coordination Group
Office of National Drug Control Policy
Washington, DC

Download Testimony
Ms. Amanda Liskamm

Ms. Amanda Liskamm
Director of Opioid Enforcement and Prevention Efforts
Office of the Deputy Attorney General
U.S. Department of Justice
Washington, DC

Download Testimony

Download Responses to Questions for the Record
Mr. William T. McDermott

Mr. William T. McDermott
Assistant Administrator
Diversion Control Division
Drug Enforcement Administration
Arlington, VA

Download Testimony

Download Responses to Questions for the Record
Dr. Neeraj Gandotra, M.D.

Chief Medical Officer

Substance Abuse And Mental Health Services Administration Department of Health and Human Services

Rockville, MD

Download Testimony

Panel II

Dr. Bradley D. Stein M.D., Ph.D.

Senior Physician Policy Researcher

RAND Corporation

Pittsburgh, PA

Download Testimony

Download Responses to Questions for the Record
Mr. Patrick M. Kelly

Mr. Patrick M. Kelly
Executive Vice President
Government Affairs
Healthcare Distribution Alliance
Arlington, VA

Download Testimony

Kelly Responses to Questions for the Record
Dr. Ronna B. Hauser, Pharm.D

Dr. Ronna B. Hauser, Pharm.D
Vice President
Policy and Regulatory Affairs National Community Pharmacists Association
Alexandria, VA

Download Testimony

Download Responses to Questions for the Record
Ms. Sue Thau

Public Policy Consultant

Community Anti-Drug Coalitions of America

Alexandria, VA

Download Testimony

Download Responses to Questions for the Record